Effect of eplerenone on markers of bone turnover in patients with primary hyperparathyroidism - The randomized, placebo-controlled EPATH trial.
Verheyen N, Grübler MR, Meinitzer A, Trummer C, Schwetz V, Amrein K, Dimai HP, März W, Catena C, von Lewinski D, Voelkl J, Alesutan I, Fahrleitner-Pammer A, Brussee H, Pilz S, Tomaschitz A.
Verheyen N, et al. Among authors: meinitzer a.
Bone. 2017 Dec;105:212-217. doi: 10.1016/j.bone.2017.08.030. Epub 2017 Sep 14.
Bone. 2017.
PMID: 28918310
Clinical Trial.